NASDAQ:RCEL AVITA Medical (RCEL) Stock Price, News & Analysis → 348 million Americans lives to END as we know it? (From The Oxford Club) (Ad) Free RCEL Stock Alerts $7.92 -0.28 (-3.41%) (As of 05/16/2024 ET) Add Compare Share Share Today's Range$7.76▼$8.3950-Day Range$7.92▼$17.1352-Week Range$7.51▼$21.70Volume358,251 shsAverage Volume220,173 shsMarket Capitalization$204.34 millionP/E RatioN/ADividend YieldN/APrice Target$24.60 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get AVITA Medical alerts: Email Address AVITA Medical MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.60 Rating ScoreUpside/Downside210.6% Upside$24.60 Price TargetShort InterestBearish6.69% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.04Based on 21 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($1.21) to ($0.26) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.12 out of 5 starsMedical Sector823rd out of 929 stocksSurgical & Medical Instruments Industry88th out of 99 stocks 3.3 Analyst's Opinion Consensus RatingAVITA Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on 3 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageAVITA Medical has only been the subject of 3 research reports in the past 90 days.Read more about AVITA Medical's stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted6.69% of the float of AVITA Medical has been sold short.Short Interest Ratio / Days to CoverAVITA Medical has a short interest ratio ("days to cover") of 6.7.Change versus previous monthShort interest in AVITA Medical has recently increased by 34.75%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldAVITA Medical does not currently pay a dividend.Dividend GrowthAVITA Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for RCEL. Previous Next 2.8 News and Social Media Coverage News SentimentAVITA Medical has a news sentiment score of 0.04. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 21 news articles for AVITA Medical this week, compared to 2 articles on an average week.Search Interest13 people have searched for RCEL on MarketBeat in the last 30 days. This is an increase of 550% compared to the previous 30 days.MarketBeat Follows7 people have added AVITA Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 40% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, AVITA Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.82% of the stock of AVITA Medical is held by insiders.Percentage Held by InstitutionsOnly 27.66% of the stock of AVITA Medical is held by institutions.Read more about AVITA Medical's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for AVITA Medical are expected to grow in the coming year, from ($1.21) to ($0.26) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of AVITA Medical is -4.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of AVITA Medical is -4.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAVITA Medical has a P/B Ratio of 4.13. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about AVITA Medical's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Behind the MarketsInvest in the "Trojan Horse" of Alzheimer's TreatmentThis one tiny Micro-Cap is at the forefront of what may be the most significant development in healthcare since the discovery of antibiotics.Click here and learn how you can invest in this incredible opportunity>>> About AVITA Medical Stock (NASDAQ:RCEL)AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.Read More RCEL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RCEL Stock News HeadlinesMay 16 at 6:30 PM | globenewswire.comAVITA Medical to Host Investor Webinar BriefingMay 16 at 4:58 AM | americanbankingnews.comAVITA Medical (NASDAQ:RCEL) Stock Rating Reaffirmed by Piper SandlerMay 16 at 3:32 AM | americanbankingnews.comAVITA Medical (NASDAQ:RCEL) PT Lowered to $21.00 at Cantor FitzgeraldMay 15 at 5:00 AM | msn.comPiper Sandler Downgrades AVITA Medical (RCEL)May 14 at 11:59 PM | markets.businessinsider.comPiper Sandler Reaffirms Their Hold Rating on Avita Medical (RCEL)May 14 at 6:59 PM | markets.businessinsider.comAnalyst Ratings For AVITA MedicalMay 14 at 8:57 AM | msn.comAVITA Medical, Inc. (NASDAQ:RCEL) Q1 2024 Earnings Call TranscriptMay 14 at 3:57 AM | finance.yahoo.comAVITA Medical Inc (AVHHL) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges ...May 13, 2024 | globenewswire.comAVITA Medical Reports First Quarter Financial ResultsMay 12, 2024 | msn.comAVITA Medical Q1 2024 Earnings PreviewApril 19, 2024 | morningstar.comAVITA Medical Inc RCELApril 15, 2024 | globenewswire.comAVITA Medical to Announce First Quarter 2024 Financial ResultsApril 11, 2024 | investing.comAvita Medical Ltd (RCEL)April 11, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Fate Therapeutics (FATE), Disc Medicine (IRON) and Avita Medical (RCEL)April 11, 2024 | seekingalpha.comBTIG downgrades Avita to neutral, cites lowered guidanceApril 10, 2024 | globenewswire.comAVITA Medical Updates Expected First Quarter 2024 RevenueMarch 16, 2024 | finance.yahoo.comRCEL Oct 2024 17.500 putMarch 16, 2024 | finance.yahoo.comRCEL Apr 2024 22.500 putMarch 5, 2024 | seekingalpha.comAVITA Medical: Unconvincing Growth Amid Fierce Competition In The Burn Care SectorFebruary 29, 2024 | finance.yahoo.comAVITA Medical Submits Response to FDA, Resuming Review Clock for RECELL GO PMA SupplementFebruary 29, 2024 | globenewswire.comAVITA Medical Submits Response to FDA, Resuming Review Clock for RECELL GO PMA SupplementFebruary 29, 2024 | globenewswire.comAVITA Medical to Present at TD Cowen 44th Annual Health Care ConferenceFebruary 26, 2024 | nasdaq.comAVITA Medical (RCEL) Price Target Increased by 6.80% to 26.69February 26, 2024 | sg.finance.yahoo.comBRIEF-Seatrium Limited Says FY Revenue S$7.3 BlnFebruary 23, 2024 | markets.businessinsider.comAvita Medical Poised for Growth: Strong Q4 Performance and Promising 2024 Outlook Reinforce Buy RatingSee More Headlines Receive RCEL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AVITA Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/13/2024Today5/16/2024Next Earnings (Estimated)8/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:RCEL CUSIPN/A CIK1762303 Webwww.avitamedical.com Phone(833) 462-8482FaxN/AEmployees207Year Founded2008Price Target and Rating Average Stock Price Target$24.60 High Stock Price Target$40.00 Low Stock Price Target$9.00 Potential Upside/Downside+210.6%Consensus RatingModerate Buy Rating Score (0-4)2.60 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($1.76) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-35,380,000.00 Net Margins-88.41% Pretax Margin-70.43% Return on Equity-74.42% Return on Assets-48.19% Debt Debt-to-Equity Ratio0.81 Current Ratio7.88 Quick Ratio7.46 Sales & Book Value Annual Sales$50.14 million Price / Sales4.08 Cash FlowN/A Price / Cash FlowN/A Book Value$1.92 per share Price / Book4.13Miscellaneous Outstanding Shares25,800,000Free Float25,330,000Market Cap$204.34 million OptionableOptionable Beta1.42 Social Links Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. James M. Corbett (Age 66)CEO, President & Executive Director Comp: $1.16MMr. David O'Toole (Age 65)Chief Financial Officer Comp: $574.64kMs. Donna Shiroma (Age 61)General Counsel, Chief Compliance Officer & Secretary Comp: $688.6kMr. David FencilSenior Vice President of Global OperationsDr. Katie Bush Ph.D.Senior Vice President of Scientific & Medical AffairsMs. Jessica EkebergInvestor Relations ExecutiveMs. Debbie GarnerSenior Vice President of Global Marketing & StrategyMr. Rob HallSenior Vice President of Human ResourcesMr. Terry BromleySenior Vice President of Global SalesDr. Niraj Doshi J.D.P.M.P., Ph.D., Senior Vice President of Product Development & Program ManagementMore ExecutivesKey CompetitorsNeuroPaceNASDAQ:NPCEUtah Medical ProductsNASDAQ:UTMDAngioDynamicsNASDAQ:ANGOProfound MedicalNASDAQ:PROFDelcath SystemsNASDAQ:DCTHView All CompetitorsInsiders & InstitutionsSilvercrest Asset Management Group LLCBought 241,665 shares on 5/16/2024Ownership: 0.937%California State Teachers Retirement SystemSold 1,610 shares on 5/16/2024Ownership: 0.010%PEAK6 Investments LLCSold 1,700 shares on 5/15/2024Ownership: 0.000%EntryPoint Capital LLCBought 13,961 shares on 5/14/2024Ownership: 0.054%Vanguard Group Inc.Bought 15,356 shares on 5/10/2024Ownership: 5.458%View All Insider TransactionsView All Institutional Transactions RCEL Stock Analysis - Frequently Asked Questions Should I buy or sell AVITA Medical stock right now? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AVITA Medical in the last twelve months. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" RCEL shares. View RCEL analyst ratings or view top-rated stocks. What is AVITA Medical's stock price target for 2024? 5 equities research analysts have issued 12 month price targets for AVITA Medical's shares. Their RCEL share price targets range from $9.00 to $40.00. On average, they predict the company's stock price to reach $24.60 in the next year. This suggests a possible upside of 210.6% from the stock's current price. View analysts price targets for RCEL or view top-rated stocks among Wall Street analysts. How have RCEL shares performed in 2024? AVITA Medical's stock was trading at $13.72 at the start of the year. Since then, RCEL shares have decreased by 42.3% and is now trading at $7.92. View the best growth stocks for 2024 here. When is AVITA Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 8th 2024. View our RCEL earnings forecast. How were AVITA Medical's earnings last quarter? AVITA Medical, Inc. (NASDAQ:RCEL) announced its earnings results on Monday, May, 13th. The company reported ($0.73) earnings per share for the quarter, missing analysts' consensus estimates of ($0.26) by $0.47. The firm had revenue of $11.10 million for the quarter, compared to the consensus estimate of $11.08 million. AVITA Medical had a negative net margin of 88.41% and a negative trailing twelve-month return on equity of 74.42%. During the same quarter in the previous year, the company earned ($0.37) EPS. What guidance has AVITA Medical issued on next quarter's earnings? AVITA Medical updated its second quarter 2024 earnings guidance on Monday, May, 13th. The company provided EPS guidance of for the period. The company issued revenue guidance of $14.3 million-$15.3 million, compared to the consensus revenue estimate of $16.7 million. What other stocks do shareholders of AVITA Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other AVITA Medical investors own include NVIDIA (NVDA), Block (SQ), Alibaba Group (BABA), Micron Technology (MU), Netflix (NFLX), PayPal (PYPL), Twilio (TWLO), AbbVie (ABBV), Inovio Pharmaceuticals (INO) and Livongo Health (LVGO). Who are AVITA Medical's major shareholders? AVITA Medical's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (5.46%), Silvercrest Asset Management Group LLC (0.94%), Hussman Strategic Advisors Inc. (0.16%), EntryPoint Capital LLC (0.05%), California State Teachers Retirement System (0.01%) and PEAK6 Investments LLC (0.00%). Insiders that own company stock include David D O'toole, Donna Shiroma, James Corbett, Jeremy Curnock Cook, Michael S Perry, Michael S Perry and Suzanne Crowe. View institutional ownership trends. How do I buy shares of AVITA Medical? Shares of RCEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:RCEL) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the MarketsObama’s Forever Term [exposed]Porter & CompanyThe 1,000X Crypto PlaybookTrue Market InsidersCharles Payne Demystifies OptionsUnstoppable ProsperityBiden FINISHED On June 13th?Paradigm PressWhy Is Gold On a MASSIVE rally? Huge AlertsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaBiden Nomination CANCELED?The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AVITA Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
